Экспрессия молекулярно-биологических маркеров при раке молочной железы с метастазами в парастернальную область

А. В. Юшкова, М. И. Нечушкин, А. Ю. Барышников et al. · Российский биотерапевтический журнал · 2005

Breast cancer is the most common oncological disease in women and is the major death cause in 35-55 years old women. The identification of needed markers for accurate prognosis and adequate treatment in breast cancer is still controversial. ' 17 patients with breast cancer with metastasis in axillar and IMN metastasis were enrolled in the study. Immunohistochemical analysis of HER-2/neu, VEGF, Ki-67, Bcl2, Bax and p53 was performed on paraffin-embedded tissue section. 4 patients (23,5 %) had disease progression 6-36 month after surgery. Follow-up period was 15-32 months. Based on the data obtained we suppose that the expression of apoptotic and angogenic markers can predict the efficacy of chemotherapy.

Cited by 0 works.

Authors